Results 171 to 180 of about 6,084,049 (334)

A Prospective Comparison of 18F-FDG PET/CT and CT as Diagnostic Tools to Identify the Primary Tumor Site in Patients with Extracervical Carcinoma of Unknown Primary Site [PDF]

open access: bronze, 2012
Anne Kirstine Hundahl Møller   +10 more
openalex   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

open access: yesMolecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz   +12 more
wiley   +1 more source

PERSPECTIVE ASUPRA HEPATITEI VIRALE E ÎN SARCINĂ

open access: yesArta Medica
Obiective. Acest articol de revizuire și analiză sistematică a literaturii de specialitate își propune ca scop evidențierea aspectelor noi ale infecției cu virusul hepatitei E în timpul sarcinii. Metode.
Octavian Sajin   +5 more
doaj  

Quality-of-Life Outcomes With Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease [PDF]

open access: bronze, 2016
Daniel B. Mark   +9 more
openalex   +1 more source

Diagnostic delay [PDF]

open access: yesBritish Dental Journal, 2013
J M, Seoane-Romero   +2 more
openaire   +2 more sources

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH

open access: gold, 2018
Anne Hwang   +17 more
openalex   +2 more sources

Communicating uncertainties when disclosing diagnostic test results for (Alzheimer's) dementia in the memory clinic: The ABIDE project [PDF]

open access: gold, 2019
Leonie N.C. Visser   +13 more
openalex   +1 more source

Home - About - Disclaimer - Privacy